RNAZ’s Financial Health: Exploring TransCode Therapeutics Inc’s Debt-to-Equity Ratio of 1.79
TransCode Therapeutics Inc’s stock market performance has been somewhat irregular. The 1-year high for the company’s stock was recorded at $128.00 on 09/25/23, with the lowest value being $0.22 on 08/14/24. 52-week price history of RNAZ Stock A stock’s 52-week high and low prices can